Zionsville, IN, United States of America

Robert D Dillard

This inventor holds 26 USPTO granted patents, primarily in Leukotriene Antagonists. Top assignees: Eli Lilly and Company, Other. Active years: 1978-2004.


% Patents Active = 96.2

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 270(Granted Patents)


Company Filing History:


Years Active: 1978-2004

Loading Chart...
Areas of Expertise:
Leukotriene Antagonists
sPLA2 Inhibitors
Indolizine Compounds
Tricyclics
Pyrroles
Phenyl Phenol
Hydrazides
Tetrazoles
Benzothiadiazine
Functional Indoles
Acetamides
Glyoxylamides
26 patents (USPTO):Explore Patents

Title: Robert D. Dillard - Pioneering Inventor from Zionsville

Introduction: Robert D. Dillard is a renowned inventor hailing from Zionsville, Indiana. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: Robert D. Dillard holds several patents in the areas of technology, healthcare, and consumer products. His recent patents focus on cutting-edge solutions for everyday challenges, showcasing his commitment to improving lives through innovation.

Career Highlights: Throughout his illustrious career, Robert D. Dillard has been recognized for his groundbreaking inventions that have reshaped industries. His dedication to pushing the boundaries of what is possible has led to numerous successes and accolades.

Collaborations: Robert D. Dillard has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the development and commercialization of his innovative ideas.

Conclusion: In conclusion, Robert D. Dillard stands as a visionary inventor whose creativity knows no bounds. His relentless pursuit of innovation continues to inspire the next generation of inventors and leaves a lasting impact on the world of technology and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…